The Union Cabinet has approved the Rs 13,038 crore Jaipur Metro Phase 2 project, a 41-km corridor with 36 stations to boost ...

North Shore Uranium Ltd. (TSXV:NSU)(OTCQB:NSURF) ("North Shore" or the "Company") is pleased to provide an update on its ...

Strong participation in recent $33 million common stock offering highlights investor confidence in late-stage clinical momentum and commercial ...

In many ways, this is only the beginning -- of a new chapter in India's nuclear story, and of a future where its vast thorium ...

The Phase 1 study is a randomized, double-blind, placebo-controlled, single ascending dose trial designed to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of IBIO-600 in ...

Armenia and the United States are actively collaborating on the execution of the Trump Route for International Peace and Prosperity (TRIPP) project, despite challenging global circumstances, as stated ...

IBIO-600 is a potentially best-in-class, long-acting anti-myostatin monoclonal antibody designed to preserve muscle and improve body compositionFirst participants expected to be dosed in 2Q 2026 SAN ...

"We are executing with urgency and purpose as we advance our pipeline assets to the clinic as expeditiously as possible," said Rick Pierce, Chief Executive Officer of Decoy Therapeutics. "We are ...

Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”) a clinical-stage biotechnology company focused on unlocking new therapeutic ...

Update will include new MRI analyses from the Phase 2b RewinD-LB clinical trial, status of global regulatory discussions, and finalized Phase 3 ...

VANCOUVER, BC / ACCESS Newswire / April 9, 2026 / North Shore Uranium Ltd. (TSXV:NSU)(OTCQB:NSURF) ("North Shore" or the ...

When you click on “Accept all”, you consent to ads on this site being customized to a personal profile we or our advertising ...